Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-16, Stock:LLY, The news for the past five days is as follows:
2019-01-09: NEWS1: CNBC'S CHRISTINA FARR & ANGELICA LAVITO: JP MORGAN'S DIMON HOSTED A DINNER FOR PHARMA EXECUTIVES, AND A MAJOR TOPIC WAS AMAZON.NEWS2: JP Morgan's Dimon hosted a dinner for pharma executives, and a major topic was Amazon.NEWS3: MERGER ALERT – BDMS, LOXO and MB: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies.NEWS4: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS5: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS6: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS7: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS8: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS9: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS10: Does Eli Lilly&apos;s $8 Billion Splurge Make Array BioPharma a Buy Now?.NEWS11: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS12: Eli Lilly and Loxo: A Robust Oncology Pipeline for Future Years.NEWS13: Pfizer or Eli Lilly: Which Company Has the Better Dividend Policy?.NEWS14: Report: Exploring Fundamental Drivers Behind Virtusa, Eli Lilly, Cree, NewJersey Resources, Getty Realty, and PennantPark Investment — New Horizons, Emerging Trends, and Upcoming Developments.NEWS15: A Pension Fund Bought Apple Stock at the Wrong Time.NEWS16: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS17: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS18: Would-Be Dealmakers Warn of M&A, IPO Delays Due to Shutdown.
2019-01-10: NEWS1: 3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year.NEWS2: 3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year.NEWS3: Will Pfizer Join The Buying Spree With This Small Biotech Stock?.NEWS4: 3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year.NEWS5: 3 Defensive ETFs to Protect Yourself From Another Market Selloff.NEWS6: Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting.NEWS7: Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting.NEWS8: Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting.NEWS9: [$$] Big Pharma’s Cancer Race.
2019-01-11: NEWS1: 5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019.NEWS2: Stock Market Rally Runs Into Resistance; Boeing, GM, Macy's, American Airlines: Weekly Review.NEWS3: Lilly eyes more cancer deals, but wary of CAR-T, gene therapy.NEWS4: 7 Pharmaceutical Stocks That Just Raised Prices This Year.NEWS5: The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock.NEWS6: The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock.NEWS7: Why Aratana Therapeutics Inc. Is Tumbling Today.NEWS8: Why Aratana Therapeutics Inc. Is Tumbling Today.NEWS9: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS10: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS11: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS12: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS13: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow.NEWS14: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow.NEWS15: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS16: Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference.NEWS17: Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference.NEWS18: The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock.NEWS19: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS20: The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference.NEWS21: The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference.NEWS22: The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference.NEWS23: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.
2019-01-14: NEWS1: Eli Lilly CEO Predicts 2019 Will Be Big Year for Biotech Acquisitions.NEWS2: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.NEWS3: Will Biogen Jump On This Biotech Stock Amid Buying Spree?.NEWS4: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS5: Here's Why Eli Lilly Stock Surged 37% in 2018.NEWS6: Here's Why Eli Lilly Stock Surged 37% in 2018.
2019-01-15: NEWS1: Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter.NEWS2: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Loxo Oncology, Inc. to Eli Lilly and Company is Fair to Shareholders.NEWS3: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS4: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS5: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS6: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS7: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.NEWS8: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.

Answer: Decrease